Free Trial

Axsome Therapeutics (AXSM) Short Interest Ratio & Short Volume

$74.62
+0.44 (+0.59%)
(As of 03:02 PM ET)

Axsome Therapeutics Short Interest Data

Current Short Interest
7,710,000 shares
Previous Short Interest
7,750,000 shares
Change Vs. Previous Month
-0.52%
Dollar Volume Sold Short
$568.69 million
Short Interest Ratio
10.5 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
47,500,000 shares
Percentage of Shares Shorted
16.23%
Today's Trading Volume
164,518 shares
Average Trading Volume
684,640 shares
Today's Volume Vs. Average
24%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Axsome Therapeutics ?

Sign up to receive the latest short interest report for Axsome Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

AXSM Short Interest Over Time

AXSM Days to Cover Over Time

AXSM Percentage of Float Shorted Over Time

Axsome Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20247,710,000 shares $568.69 million -0.5%N/A10.5 $73.76
4/15/20247,750,000 shares $528.63 million +1.3%N/A10.7 $68.21
3/31/20247,650,000 shares $610.47 million +4.8%N/A10.4 $79.80
3/15/20247,300,000 shares $551.44 million -2.3%N/A9.4 $75.54
2/29/20247,470,000 shares $607.91 million -0.7%N/A10.2 $81.38
2/15/20247,520,000 shares $702.82 million +0.4%N/A10.9 $93.46
1/31/20247,490,000 shares $674.32 million -10.0%N/A11.5 $90.03
1/15/20248,320,000 shares $708.95 million -1.2%N/A11.9 $85.21
12/31/20238,420,000 shares $670.15 million +0.7%N/A12.4 $79.59
12/15/20238,360,000 shares $610.20 million -1.1%N/A12.6 $72.99
11/30/20238,450,000 shares $569.95 million +10.6%N/A12.3 $67.45
11/15/20237,640,000 shares $460.00 million +4.0%N/A11.5 $60.21
10/31/20237,350,000 shares $457.76 million -3.2%N/A11 $62.28
10/15/20237,590,000 shares $504.51 million +1.6%N/A10.9 $66.47
9/30/20237,470,000 shares $522.08 million -8.0%N/A10.4 $69.89
9/15/20238,120,000 shares $611.11 million -1.5%N/A9.6 $75.26
8/31/20238,240,000 shares $665.79 million -3.5%N/A9.3 $80.80
8/15/20238,540,000 shares $609.41 million -5.7%N/A9.4 $71.36
7/31/20239,060,000 shares $710.94 million -2.6%N/A9.6 $78.47
7/15/20239,300,000 shares $684.76 million +1.8%N/A10.5 $73.63
6/30/20239,140,000 shares $656.80 million +17.8%24.5%10.1 $71.86
6/15/20237,760,000 shares $656.73 million +0.3%22.2%9.9 $84.63
5/31/20237,740,000 shares $571.06 million +0.9%22.2%9.9 $73.78
5/15/20237,670,000 shares $596.50 million -4.0%22.0%9.1 $77.77
4/30/20237,990,000 shares $571.52 million +1.9%23.3%8.9 $71.53
4/15/20237,840,000 shares $537.04 million -4.5%22.8%8.6 $68.50
3/31/20238,210,000 shares $506.39 million -3.8%23.9%8.7 $61.68
3/15/20238,530,000 shares $528.26 million +1.6%24.8%8.9 $61.93
2/28/20238,400,000 shares $572.80 million +4.4%24.5%8.5 $68.19
2/15/20238,050,000 shares $508.28 million +5.4%23.5%6.9 $63.14
1/31/20237,640,000 shares $573 million -3.8%21.6%6.2 $75.00
1/15/20237,940,000 shares $534.36 million +5.2%22.4%5.9 $67.30
12/30/20227,550,000 shares $582.33 million +2.4%21.3%5.4 $77.13
12/15/20227,370,000 shares $570.88 million -7.1%20.8%5.1 $77.46
11/30/20227,930,000 shares $573.26 million +16.8%22.8%5.3 $72.29
11/15/20226,790,000 shares $372.91 million +9.0%19.5%5.2 $54.92
10/31/20226,230,000 shares $281.28 million +8.5%19.3%3.6 $45.15
10/15/20225,740,000 shares $275.52 million +2.5%17.8%3.7 $48.00
9/30/20225,600,000 shares $249.87 million -1.8%17.4%3.8 $44.62
9/15/20225,700,000 shares $351.63 million -3.7%17.7%2.9 $61.69
Memorial Day Sale! Get 90% OFF Behind the Markets! (Ad)

Today, I'm offering you the chance to receive a PLATINUM BTM subscription for up to 90% OFF! If you want to see just how much your mystery discount is...

You can UNCOVER YOUR MYSTERY DISCOUNT HERE!
8/31/20225,920,000 shares $377.70 million +8.4%18.5%3.1 $63.80
8/15/20225,460,000 shares $258.64 million -5.0%17.1%3 $47.37
7/31/20225,750,000 shares $221.89 million -3.9%18.7%4.2 $38.59
7/15/20225,980,000 shares $261.27 million +7.4%19.5%4.1 $43.69
6/30/20225,570,000 shares $213.33 million +6.5%18.1%3.4 $38.30
6/15/20225,230,000 shares $120.29 million +4.8%17.0%3.6 $23.00
5/31/20224,990,000 shares $124.75 million +2.5%16.3%4.7 $25.00
5/15/20224,870,000 shares $135.87 million +7.7%15.9%4.6 $27.90
4/30/20224,520,000 shares $143.51 million -0.9%14.8%4.3 $31.75
4/15/20224,560,000 shares $168.08 million -4.6%15.0%4.7 $36.86
3/31/20224,780,000 shares $197.84 million +5.8%15.9%6.6 $41.39
3/15/20224,520,000 shares $131.67 million +2.3%15.0%7 $29.13
2/28/20224,420,000 shares $124.25 million +17.6%14.7%7.1 $28.11
2/15/20223,760,000 shares $126.90 million +8.4%12.7%6.3 $33.75
1/31/20223,470,000 shares $95.22 million +4.2%11.8%5.5 $27.44
1/15/20223,330,000 shares $95.24 million -2.9%11.3%5.5 $28.60
12/31/20213,430,000 shares $129.59 million -5.0%11.6%5.4 $37.78
12/15/20213,610,000 shares $118.30 million +2.9%12.2%5 $32.77
11/30/20213,510,000 shares $121.24 million +7.7%11.9%4.2 $34.54
11/15/20213,260,000 shares $125.44 million -2.1%11.0%3.5 $38.48
10/29/20213,330,000 shares $128.21 million -11.4%11.2%2.5 $38.50
10/15/20213,760,000 shares $150.78 million -0.3%12.7%2.6 $40.10
9/30/20213,770,000 shares $124.26 million +12.5%12.7%2.8 $32.96
9/15/20213,350,000 shares $92.86 million -16.5%11.3%2.7 $27.72
8/31/20214,010,000 shares $102.98 million +17.9%13.5%3.5 $25.68
8/13/20213,400,000 shares $77.72 million +15.3%11.5%3.4 $22.86
7/30/20212,950,000 shares $143.34 million +8.5%10.0%4.8 $48.59
7/15/20212,720,000 shares $154.41 million -6.2%9.2%6.9 $56.77
6/30/20212,900,000 shares $195.63 million -12.9%9.8%7.7 $67.46
6/15/20213,330,000 shares $223.81 million -2.1%11.3%8.9 $67.21
5/28/20213,400,000 shares $206.41 million +4.3%11.5%9.2 $60.71
5/14/20213,260,000 shares $195.70 million +5.2%11.0%8.9 $60.03
4/30/20213,100,000 shares $191.52 million +7.3%10.5%8.7 $61.78
4/15/20212,890,000 shares $154.76 million -0.3%9.8%8.7 $53.55
3/31/20212,900,000 shares $162.14 million -8.5%9.9%9.7 $55.91
3/15/20213,170,000 shares $210.77 million -1.3%10.8%10.2 $66.49
2/26/20213,210,000 shares $219.50 million +4.2%10.9%10.2 $68.38
2/12/20213,080,000 shares $227.00 million -8.6%10.5%10 $73.70
1/29/20213,370,000 shares $235.36 million +0.6%11.5%10.7 $69.84
1/15/20213,350,000 shares $267.63 million -3.2%11.4%10.7 $79.89
12/31/20203,460,000 shares $288.08 million +2.4%11.8%11.4 $83.26
12/15/20203,380,000 shares $270.23 million +1.2%11.5%10.7 $79.95
11/30/20203,340,000 shares $251.10 million -3.5%11.4%9.3 $75.18
11/15/20203,460,000 shares $256.66 million +0.3%11.8%9.5 $74.18
10/30/20203,450,000 shares $234.70 million -4.7%11.8%9.3 $68.03
10/15/20203,620,000 shares $270.16 million -5.2%12.4%9.4 $74.63
9/30/20203,820,000 shares $272.18 million +4.1%13.1%9.4 $71.25
9/15/20203,670,000 shares $298.22 million -4.4%12.6%7.8 $81.26
8/31/20203,840,000 shares $281.51 million -1.0%13.1%8.4 $73.31
8/14/20203,880,000 shares $306.52 million +0.3%13.3%8.1 $79.00
Discover little-known stocks with HUGE potential to soar in 2024 (Ad)

Imagine having the power to identify stocks that are flying under the radar, yet hold the potential to deliver jaw-dropping returns. Identifying these hidden gems before they go mainstream can be a game-changer for you.

Claim your free Wealth Building Report by clicking here now.
7/31/20203,870,000 shares $276.05 million No Change13.5%7.3 $71.33
7/15/20203,870,000 shares $307.36 million +0.3%13.5%5.7 $79.42
6/30/20203,860,000 shares $317.60 million +9.0%13.4%5.1 $82.28
6/15/20203,540,000 shares $255.84 million +4.1%12.3%4.3 $72.27
5/29/20203,400,000 shares $261.73 million -0.9%11.8%3.5 $76.98
5/15/20203,430,000 shares $298.00 million -4.5%11.9%3.4 $86.88
4/30/20203,590,000 shares $341.16 million -14.9%12.5%3.6 $95.03
4/15/20204,220,000 shares $271.89 million +8.5%14.6%4.8 $64.43
3/31/20203,890,000 shares $297.20 million -6.5%13.5%4.4 $76.40
3/13/20204,158,800 shares $233.52 million +10.0%20.1%5.5 $56.15
2/28/20203,780,000 shares $241.58 million -4.1%18.2%3.3 $63.91
2/14/20203,940,000 shares $305.39 million -3.0%13.8%3.2 $77.51
1/31/20204,060,000 shares $340.31 million +1.8%14.2%3.1 $83.82
1/15/20203,990,000 shares $370.27 million -20.7%13.9%3 $92.80
12/31/20195,030,000 shares $428.56 million -6.0%17.6%3.7 $85.20

AXSM Short Interest - Frequently Asked Questions

What is Axsome Therapeutics' current short interest?

Short interest is the volume of Axsome Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 7,710,000 shares of AXSM short. Learn More on Axsome Therapeutics' current short interest.

What is a good short interest ratio for Axsome Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXSM shares currently have a short interest ratio of 10.0. Learn More on Axsome Therapeutics's short interest ratio.

Which institutional investors are shorting Axsome Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Axsome Therapeutics: Walleye Trading LLC, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Axsome Therapeutics' short interest increasing or decreasing?

Axsome Therapeutics saw a drop in short interest in April. As of April 30th, there was short interest totaling 7,710,000 shares, a drop of 0.5% from the previous total of 7,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Axsome Therapeutics' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Axsome Therapeutics: Insmed Incorporated (5.74%), HUTCHMED (China) Limited (0.26%), Biohaven Ltd. (10.91%), Ultragenyx Pharmaceutical Inc. (5.59%), Perrigo Company plc (2.54%), Alkermes plc (7.62%), Prestige Consumer Healthcare Inc. (3.79%), Arrowhead Pharmaceuticals, Inc. (7.74%), IDEAYA Biosciences, Inc. (16.17%), Summit Therapeutics Inc. (28.19%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Axsome Therapeutics stock?

Short selling AXSM is an investing strategy that aims to generate trading profit from Axsome Therapeutics as its price is falling. AXSM shares are trading up $0.44 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Axsome Therapeutics?

A short squeeze for Axsome Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXSM, which in turn drives the price of the stock up even further.

How often is Axsome Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXSM, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:AXSM) was last updated on 5/24/2024 by MarketBeat.com Staff

From Our Partners